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In the hierarchy of evidence that is
used to support clinical and public
health decisions, systematic reviews of
randomized trials are at the top of the
list, followed by individual randomized
trials and multiple time series, and then
other types of observational studies. For
keratinocyte carcinomas (basal and
squamous cell carcinomas of the skin),
the most common malignancies in the
developed world, evidence for preven-
tion of these lesions had been relatively
low on this hierarchy of evidence
during the entire 20th century. At least
for squamous cell carcinoma, a good
animal model was well established,
with a known action spectrum (de
Gruijl et al., 1993), but rodents did
not develop melanomas as readily,
and a fish model of melanoma had
suggested that UVA was most
important in causing melanoma
(Setlow et al., 1993). Debates raged
over whether sunscreens were of any
benefit; some argued that they may just
serve to increase the amount of time
that users spend in the sun, hence
ultimately increasing skin cancer risk.
This last argument was supported by
a frequently cited study of University
students who increased their time in
the sun during a spring vacation while
using a sunscreen with a higher SPF
(Sun Protection Factor; Autier et al.,
1999). Some other studies did not find
this association (Dupuy et al., 2005).
However, there were numerous case–
control studies that failed to observe an
association between sunscreen use
history and melanoma, or that found
that greater sunscreen use was asso-
ciated with greater melanoma risk.
A key weakness in these case–
control studies was confounding, and
particularly confounding by indication:
those participants with the greatest skin
cancer risk were particularly likely to
use sunscreen because of that strong
risk. Hence, a case–control study
would be likely to observe a direct
association between sunscreen use and
subsequent skin cancer, not because
the sunscreens cause the cancer but
because sunscreen use was the best
available measure of skin cancer risk.
This artifact is notoriously difficult to
disentangle from true biological cause-
and-effect associations without a ran-
domized experimental intervention.
Twenty years ago, even though UV
radiation was thought to be a key cause
of the common skin cancers based on
many lines of evidence, the quality of the
evidence to support the use of sunsc-
reens for the prevention of these cancers
was lacking strong empirical validation.
Yet this issue was of substantial public
health importance; authorities needed
stronger evidence to devote the needed
resources to encourage sunscreen use.
Hence, a landmark randomized trial was
launched to gather a higher level of
evidence. It was conducted by a team in
Queensland, Australia, the area with the
highest incidence of skin cancer in the
world. A general population sample of
1621 residents (aged 20–69 years) of
Nambour, a town in southwest Queens-
land, was randomized either to continue
their usual pattern of sunscreen use or to
apply an SPF 16 sunscreen every morn-
ing to the exposed areas of the head,
neck, arms, and hands. During 4.5 years
of follow-up, the sunscreen group devel-
oped 39% fewer squamous cell carcino-
mas on the head, neck, arms, and hands
than the control group (Green et al.,
1999).
An additional 8 years of follow-up
was obtained on this cohort, and
the nearly 40% reduction in squamous
cell carcinomas persisted (Van der Pols
et al., 2006). Most recently, a 50%
reduction in melanomas was noted
after a total of nearly 15 years of follow-
up (Green et al., 2011). No other
adequately powered randomized trials
of sunscreen use for skin cancer
prevention have been published.
The United States Food and Drug
Administration (FDA) has heard exten-
sive arguments regarding labeling of
sunscreens, including a major focus on
allowing manufacturers to claim that
sunscreen use can reduce the risk of
some skin cancers. These arguments
relied heavily on the findings of the
Nambour study, and the FDA has now
promulgated regulations that explicitly
allow marketing of sunscreens with an
SPF greater than 15 to claim that
appropriate use can lead to reduction
in skin cancer risk. Sunscreens have
improved in multiple respects over the
past 20 years. In particular, higher SPFs
are now quite commonly used. Never-
theless, to this day, this remarkable
data from Nambour provide the high-
est-level evidence that the use of
sunscreens of adequate SPF, when
applied consistently, leads to reduction
in skin cancer risk, and important
public health action has followed.
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